Sharekhan

Biofil Chemicals and Pharmaceuticals Ltd

Mon 6/10/2025,15:57:49 | NSE : BIOFILCHEM

₹ 41.01-0.34 (-0.82%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 40.99

Previous Close

₹ 41.35

Volume

7218

Mkt Cap ( Rs. Cr)

₹66.74

High

₹ 42.38

Low

₹ 40.99

52 Week High

₹ 80.70

52 Week Low

₹ 40.30

Book Value Per Share

₹ 11.54

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Biofil Chemicals and Pharmaceuticals Ltd

Your Vote -

Buy

39.06%

Hold

7.81%

Sell

53.13%

39.06%

64 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

41.01

50

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

50

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Biofil Chemicals and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Biofil Chemicals - Trading Window

    29 Sep 2025, 7:23PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tra
  • Biofil Chemicals - Change in Management

    29 Sep 2025, 5:37PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about following events for which disclosure as required under Regulation 30 rea
  • Biofil Chemicals - General Updates

    29 Sep 2025, 3:50PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Scruitinizer report and voting result in pdf form.
  • Biofil Chemicals - Shareholders meeting

    29 Sep 2025, 3:12PM Biofil Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2025
  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Management

    29 Sep 2025, 5:21PM Continuous Disclosure of following material events or information for which disclosure as required under sub-clause 7 of Part A Para A of Schedule III
  • Biofil Chemicals - Scrutinizer Report With Voting Result

    29 Sep 2025, 3:36PM Scrutinizer report with voting result
  • Biofil Chemicals - Scrutinizer Report With Voting Result

    29 Sep 2025, 3:25PM Scrutinizer report with voting result
  • Biofil Chemicals - Shareholders meeting

    27 Sep 2025, 8:24PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2025.
  • Biofil Chemicals - Summary Of Proceedings Of 40Th Annual General Meeting Of The Company Held On Saturday, 27Th September, 202

    27 Sep 2025, 8:02PM Summary of Proceeding of 40th Annual General Meeting of the Company held on Saturday, 27th September, 2025 .
  • Biofil Chemicals - Shareholders meeting

    15 Sep 2025, 6:31PM Biofil Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Scrutinizer report of Postal Ballot
  • Biofil Chemicals - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    15 Sep 2025, 5:51PM Submission of voting results of postal ballot and report of Scrutinizer
  • Biofil Chemicals - Copy of Newspaper Publication

    1 Sep 2025, 12:28PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30, 44 and 47 of SEBI
  • Biofil Chemicals - General Updates

    29 Aug 2025, 7:08PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about intimation of e-voting
  • Biofil Chemicals - General Updates

    29 Aug 2025, 7:05PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not register
  • Biofil Chemicals - Shareholders meeting

    29 Aug 2025, 6:53PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 27, 2025
  • Biofil Chemicals - Information Regarding E-Voting For 40Th Annual General Meeting

    29 Aug 2025, 6:45PM Information under Regulation 44 of SEBI (LODR) Regulation, 2015 and Section 108 of Companies Act, 2013 regarding Voting through Electronic mode for th
  • Biofil Chemicals - Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Com

    29 Aug 2025, 6:41PM Intimation for Dispatch of Letter to those Shareholders whose e-mail addresses are not registered with company/ registrar & transfer agent/ depository
  • Biofil Chemicals - Reg. 34 (1) Annual Report.

    29 Aug 2025, 6:37PM Submission of Annual Report for the Financial Year 2024-25 pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) Regulatio
  • Biofil Chemicals - Submission Of Notice Of Convening 40Th AGM Of The Company.

    29 Aug 2025, 6:29PM Submission of Notice of 40th AGM scheduled to be held on Saturday 27th September, 2025 at 03:00 P.M. (IST) through video conference (VC)/Other audio v
  • Biofil Chemicals - Appointment

    23 Aug 2025, 6:55PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Smitesh Shah (DIN: 00326182) as Non- Executive Direct
  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Directorate

    23 Aug 2025, 6:27PM Appointment of Mr. Smitesh Shah (DIN: 00326182) as an Additional Director under the category of Promoter Non- Executive Non Independent Director of th
  • Biofil Chemicals - Copy of Newspaper Publication

    22 Aug 2025, 1:08PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Publication of Notice of AGM through Video Conferencing (''VC'')/
  • Biofil Chemicals - Copy of Newspaper Publication

    14 Aug 2025, 12:56PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Biofil Chemicals - Change in Management

    12 Aug 2025, 8:51PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Re-Appointment of Independent Directors
  • Biofil Chemicals - Address Change

    12 Aug 2025, 8:48PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding change in Registered Office of the company.
  • Biofil Chemicals - Appointment

    12 Aug 2025, 8:35PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of KETAN SHAH as Chairman & Managing Director of the compa
  • Biofil Chemicals - Change in Management

    12 Aug 2025, 8:32PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Appointment of Secretarial Auditor
  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Management

    12 Aug 2025, 8:24PM Appointment of Chairman
  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Management

    12 Aug 2025, 8:22PM Appointment of Managing Director
  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Management

    12 Aug 2025, 8:20PM Appointment of Secretarial Auditor
  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Directorate

    12 Aug 2025, 8:18PM Re-appointment of Independent Director.
  • Biofil Chemicals - Outcome of Board Meeting

    12 Aug 2025, 8:04PM Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
  • Biofil Chemicals Q1 net profit zooms 1317.65% at Rs 2.41 cr

    12 Aug 2025, 8:00PM The company reported standalone net profit of Rs 2.41 crore for the quarter ended June 30, 2025 as compared to Rs 0.17 crore in the same period last y
  • Biofil Chemicals - Outcome of Board Meeting

    12 Aug 2025, 7:45PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 12, 2025.
  • Biofil Chemicals - Un-Audited Financial Results For The Quarter Ended 30Th June 2025

    12 Aug 2025, 7:33PM Un-Audited Financial Results for the quarter ended 30th June 2025
  • Biofil Chemicals - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 12Th August, 2025 Pursuant To Regulatio

    12 Aug 2025, 7:26PM Outcome of Board Meeting held on Tuesday 12th August, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulati
  • Biofil Chemicals - Copy of Newspaper Publication

    12 Aug 2025, 3:02PM NEWSPAPER ADVERTISEMENT REGARDING THE DISPATCH OF POSTAL BALLOT NOTICE AND REMOTE E-VOTING
  • Biofil Chemicals - Shareholders meeting

    8 Aug 2025, 4:46PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot
  • Biofil Chemicals - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    8 Aug 2025, 4:29PM Notice of Postal Ballot
  • Biofil Chemicals - Disclosure of material issue

    4 Aug 2025, 7:08PM Biofil Chemicals & Pharmaceuticals Limited has informed regarding Disclosure of material issue
  • Biofil Chemicals - Outcome of Board Meeting

    4 Aug 2025, 6:59PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 04, 2025.
  • Biofil Chemicals - Continuous Disclosure Under Sub-Para 1 Of Para A Of Part A Of Schedule III Of The SEBI (LODR) Regulations,

    4 Aug 2025, 6:48PM Sell, transfer or otherwise dispose the lease hold right of Industrial land subject to approval of members.
  • Biofil Chemicals - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 04Th August, 2025 Pursuant To Regulation

    4 Aug 2025, 6:36PM Outcome of Board Meeting held on Monday 04th August, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulati
  • Biofil Chemicals has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 4:20PM As of June 2025, 46.82% is owned by Indian Promoters and 53.18% by Public. <p align=justify> Top five Promoters holding highest number of shares of Bi

Key fundamentals

Evaluate the intrinsic value of Biofil Chemicals and Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 19.2527 18.6417 17.8268 17.3024 16.5589
Liabilities 19.2527 18.6417 17.8268 17.3024 16.5589
Equity 16.2738 16.2738 16.2738 16.2738 16.2738
Gross Profit 0.8474 0.8165 1.1676 1.3327 1.5991
Net Profit 0.5577 0.7092 0.5604 0.6984 1.2414
Cash From Operating Activities -1.9237 2.3937 -0.1118 -0.2199 1.1109
NPM(%) 1.66 1.77 1.86 3.12 3.47
Revenue 33.4022 40.0353 30.0352 22.3823 35.7504
Expenses 32.5548 39.2188 28.8676 21.0496 34.1513
ROE(%) 2.96 3.77 2.98 3.71 6.6

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Biofil Chemicals and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 791.40 0.50 71.75 23.41 301.39 0.63
Lotus Eye Hospital and Institute Ltd 122.14 0.66 394.00 85.29 3.55 0.00
Vaishali Pharma Ltd 11.37 1.16 379.00 535.03 3.13 0.00
Astec Lifesciences Ltd 798.75 0.38 0.00 80.43 -604.77 0.00

Company Info

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.

Read More

Parent Organisation

Biofil Chemicals & Pharmaceuticals Ltd.

Founded

04/01/1985

Managing Director

Mr.Ketan Shah

NSE Symbol

BIOFILCHEMEQ

FAQ

The current price of Biofil Chemicals and Pharmaceuticals Ltd is ₹ 41.01.

The 52-week high for Biofil Chemicals and Pharmaceuticals Ltd is ₹ 42.38 and the 52-week low is ₹ 40.99.

The market capitalization of Biofil Chemicals and Pharmaceuticals Ltd is currently ₹ 66.74. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Biofil Chemicals and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Biofil Chemicals and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Biofil Chemicals and Pharmaceuticals Ltd shares.

The CEO of Biofil Chemicals and Pharmaceuticals Ltd is Mr.Ketan Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT